Giulio POMPILIO

Friday, 14 January 2022 | 12:00 noon – ICGEB Trieste, ITALY

Scientific Director, Centro Cardiologico Monzino IRCCS, Associate Professor of Cardiac Surgery, Department of Biomedical, Surgical and Dental Science, University of Milano ITALY

Cell therapy for refractory angina: from bench to bedside

(Host: S. Zacchigna)

In the cardiovascular arena, refractory available is one of the most promising unmet targets for cell therapy. In the seminar, avaiable preclinical ,regulatory and clinical evidences will be analysed, focusing on the roadmap leading to the Phase I clinical trial completed at Centro Cariologico Monzino IRCCS.